Search

everythinglearnresearchcommunity

for

Search:↓

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

H19 may help cause PCOS by affecting CTGF levels, suggesting a new treatment target.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Tofacitinib helped regrow hair in most patients with severe hair loss.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Including androgens in hormone therapy may lower breast cancer risk.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Targeting senescent cells may offer new treatments for PCOS.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Certain variations in the vitamin D receptor gene are linked to an increased risk of polycystic ovary syndrome.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.